The Neck Cloud announces expanded availability of its chiropractor-tested cervical traction device, designed to relieve ...

The Neck Cloud requires just 10 minutes daily to combat tech neck and study-induced pain that plagues university students.

Lithuanian-Made Cervical VNS Technology Reaches 100,000+ Users Worldwide as FCC-Certified Wellness Devices Gain Traction for ...

The global cervical dystonia market is thriving, driven by increased disease prevalence, advancements in neuromodulation techniques, and heightened awareness of movement disorders. Key factors include ...

For those with decades left in their investing journey, these top healthcare stocks could be worthy portfolio contenders.

Neuralink's N1 device aims to restore mobility and vision, presenting significant medical potential. Neuralink is privately held, not publicly traded, limiting direct investment opportunities.

The FDA approved Eylea HD for the treatment of macular edema following retinal vein occlusion, according to a press release.